3-(4-((4-(Morpholinomethyl-Benzyl)oxy)-1 -Oxoisoindolin-2-Yl)piperidine-2,6-Dione for the Treatment of Systemic Lupus Erythematosus
Copyright © Targeted News Service, 2023
2023-05-30
Copyright © Targeted News Service, 2023
2023-05-30
ALEXANDRIA, Virginia, May 30 -- CELGENE CORPORATION, Summit, New Jersey has been assigned a patent (No. US 11660302 B2, initially filed March 29, 2021) developed by three inventors Peter H. Schafer, Belle Mead, New Jersey; Lei Wu, Bridgewater, New Jersey; and Ying Ye, Branchburg, New Jersey, for "3-(4-((4-(morpholinomethyl-benzyl)oxy)-1 -oxoisoindolin-2-yl)piperidine-2,6-dione for the treatment of systemic lupus erythematosus." . . .